Consolidation and Integration in Health Care: What It Means for Patients, Payers, and Policy

Why It Matters

Consolidation shapes pricing, access, and competition across the system—driving higher spending for employers and consumers and complicating oversight of insurer and provider power. Policymakers and purchasers face pressure to curb anti-competitive behavior or promote alternative integration models that demonstrably lower costs.

Summary

Speakers outlined how decades-long consolidation in U.S. health care has accelerated into new forms of vertical integration: hospitals acquiring physician practices, insurers buying providers and PBMs, and conglomerates building end-to-end platforms. While companies argue these moves improve coordination and efficiency, emerging evidence links many integrations to higher commercial prices, increased utilization, and greater Medicare Advantage revenues via risk coding rather than clear cost savings. Panelists noted a contrasting example in Kaiser’s fully integrated model, which has delivered lower premiums and strong market acceptance, but said most recent mergers haven’t replicated those benefits. The trend has drawn bipartisan political scrutiny and renewed calls for regulatory limits or structural remedies.

Original Description

News reports across the country trumpet major mergers and consolidation involving health insurers, physician practices, pharmacy benefit managers, hospitals and health systems, and other providers, including many that integrate different services under a single umbrella. The wave of consolidation and integration has federal and state policy makers examining how it affects competition, prices, and overall costs.

On February 18, 2026, three experts joined moderator Larry Levitt for an hour-long “Health Wonk Shop” discussion about health care consolidation and integration. During the event, panelists discussed the motivations behind horizontal and vertical consolidation in health care, its potential to lower or raise costs, the implications for patients and payers, and how policy makers could respond.